|Topic:||Giving Full Measure to Countermeasures: Addressing Problems in the DoD Program to Develop Medical Countermeasures Against Biological Warfare Agents|
THE NATIONAL ACADEMIES
Institute of Medicine
Medical Follow-Up Agency
National Research Council
Board on Life Sciences
Committee on Accelerating the Research, Development, and Acquisition of Medical Countermeasures
Against Biological Warfare Agents
Monday, January 12, 2004 -- 9:00 a.m.
2212 Rayburn House Office Bldg.
Giving Full Measure to Countermeasures:
Addressing Problems in the DoD Program to
Develop Medical Countermeasures Against Biological Warfare Agents
Requested by Congress in PL 107-107, this new report reviews the Department of Defense's process for acquiring drugs, vaccines, and other medical countermeasures against biowarfare agents. The report also recommends steps that should be taken to accelerate the development and licensure of safe and effective products.
This briefing was for members of Congress and congressional staff only. The report was publicly released on January 22, 2004 and is available, in its entirety, on the Web site of the National Academies Press.